Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy

Samankaltaisia teoksia

• Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
  Tekijä: Pace, D, et al.
  Julkaistu: (2015)
• Will booster doses be required for serogroup B meningococcal vaccine?
  Tekijä: McQuaid, F, et al.
  Julkaistu: (2014)
• Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
  Tekijä: Khatami, A, et al.
  Julkaistu: (2011)
• Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
  Tekijä: Snape, MD, et al.
  Julkaistu: (2009)
• Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
  Tekijä: Khatami, A, et al.
  Julkaistu: (2012)